NIV with total face mask managed acute respiratory failure in two patients with Madelung's disease and COVID-19 pneumonia
This case series reports on the use of non-invasive ventilation using a total face mask in a population of patients with Madelung's disease. The sample size was two individuals who presented with acute respiratory failure, COVID-19 pneumonia, or obstructive sleep apnea. The primary outcome of interest was the management of acute respiratory failure, which was successfully managed in both cases. No specific adverse event rates or p-values were reported for the primary outcomes. However, bilateral pneumothoraxes were noted as adverse events in the safety profile. The study setting and follow-up duration were not reported. The authors note that the small sample size and observational nature of the data limit the ability to draw definitive conclusions about efficacy or safety across a wider population. Despite these limitations, the findings suggest that a proactive NIV-first approach is a viable and potentially life-saving strategy for this specific clinical scenario. Clinicians should interpret these results with caution given the lack of a control group and the very limited number of participants.